February 18, 2016

Intellectual Property and FDA Considerations for Biotechnology and Medical Device Projects

Overview

Effective product development in the medical device and biotechnology industries requires a company to understand both the intellectual property (IP) and Food and Drug Administration (FDA) implications of its work. By proposing a series of questions that participants can use to assess their projects, this seminar will help engineers, designers and project managers to better understand the medical device and biotechnology product development process. Companies integrating knowledge of FDA regulatory requirements and IP portfolio management into their product development processes are more likely to experience success.  

  • Understanding the basics of patent and FDA regulatory application processes
  • Identifying key intersection points between patent application and FDA regulatory processes
  • Implementing practical workforce tools for successful product development
Location

Hamline University – Minneapolis
1600 Utica Avenue South
7th Floor
Saint Louis Park, MN 55416

Services and Industries

Agenda

7:30 a.m. to 8:30 a.m. (registration)
8:00 a.m. to 9:30 a.m. (program)

Faegre Baker Daniels 网站使用 Cookie 来提升您的浏览体验。